Monday 9 November 2026 Export IKT’s income statement to Excel — free account

Inhibikase Therapeutics, Inc.

IKT

Inhibikase Therapeutics, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $260,500.00, up 111.1% from fiscal 2022.

EPS: 0.00%
Free cash flow: −123.2%

Quarter to June 2026, against a year earlier

Revenue growth 3 yrs

1.50 0.06 +4.17%

Follow IKT

Alert me

Market cap: $209.3M
P/E: n/m
Fwd P/E: n/m
Dividend yield: —
F-score: 3/9
ROIC: 0.00%
Net debt / EBITDA: 3.4×
Dividend safety: n/a

Overview

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	—	—	—	—	+8 more quarters Free account
EV/Sales Full definition →	—	—	—	—
EV/FCF Full definition →	—	—	—	—
Quick Ratio Full definition →	15.50	29.83	21.54	11.55
Current Ratio Full definition →	15.82	30.14	21.70	11.73
Net Debt/EBITDA Full definition →	7.55	9.55	12.98	6.07
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.64	0.74	0.59	0.89
Capex/Depreciation Full definition →	—	—	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Yield Full definition →	—	—	—	—
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.07)	(0.07)	(0.08)	(0.12)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.07)	(0.07)	(0.08)	(0.12)
Cash per Share Full definition →	0.91	0.99	1.82	0.86
Shareholders Equity per Share Full definition →	0.88	0.97	1.76	0.81
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.88	0.97	1.76	0.81
Free Cash Flow Full definition →	(12.44)	(12.06)	(7.52)	(10.59)
Working Capital Full definition →	152.08	166.46	171.81	71.84
Capital Expenditures Full definition →	—	—	0.00	0.00
Net Current Asset Value Full definition →	152.08	166.46	171.81	71.84
EV/EBIT Full definition →	—	—	—	—
Capex to Sales Full definition →	—	—	0.00	0.00
Other line items
Average Payables Full definition →	1.85	1.64	1.05	1.57
Average Assets Full definition →	126.22	133.81	139.90	41.99
Average Common Equity Full definition →	116.69	126.68	133.89	36.18

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly